SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Research analysts at National Bank Financial cut their Q2 2025 earnings estimates for SNC-Lavalin Group in a research report issued to clients and investors on Thursday, March 13th. National Bank Financial analyst M. Sytchev now anticipates that the company will earn $0.65 per share for the quarter, down from their previous estimate of $0.77. National Bank Financial also issued estimates for SNC-Lavalin Group’s Q3 2025 earnings at $0.73 EPS, Q4 2025 earnings at $0.89 EPS and FY2026 earnings at $3.49 EPS.
Separately, Stifel Canada upgraded shares of SNC-Lavalin Group to a “strong-buy” rating in a research report on Tuesday, February 4th.
SNC-Lavalin Group Price Performance
SNC-Lavalin Group Company Profile
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Featured Stories
- Five stocks we like better than SNC-Lavalin Group
- What is the S&P/TSX Index?
- How to Build the Ultimate Everything ETF Portfolio
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to Read Stock Charts for Beginners
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
